drug-induced liver injury

Ask MedXY AI

Latest news

Tag

Gastroenterologydrug-induced liver injuryDILI

Navigating Drug-Induced Liver Injury in Clinical Trials: Insights and Updates from FDA Experts

By MedXY|Sep 7, 2026

Drug-Induced Liver Injury (DILI) remains a pivotal challenge in drug development, with evolving drug modalities and clinical trial designs prompting updated regulatory perspectives from FDA specialists.

Gastroenterologydrug-induced liver injuryMASLD

Reclassifying Pediatric NAFLD: Insights from the Steatotic Liver Disease Framework in a Multicenter NASH CRN Study

By MedXY|Jul 15, 2026

A multicenter study reclassifies pediatric NAFLD under the steatotic liver disease framework, revealing most children meet MASLD criteria, while highlighting alcohol and medication-related reclassifications that inform diagnosis and managem